Cargando…

Poliovirus neutralizing antibody levels among individuals in three regions of Ghana

INTRODUCTION: Ghana was declared polio-free in 2015 after the last polio case in 2008. We determined the poliovirus neutralizing antibody levels among individuals to identify possible immunity gaps. METHODS: A cross-sectional, hospital-based study was undertaken in Northern, Ashanti and Greater Accr...

Descripción completa

Detalles Bibliográficos
Autores principales: Opare, Joseph KL, Akweongo, Patricia, Afari, Edwin A, Odoom, John k
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ghana Medical Association 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697761/
https://www.ncbi.nlm.nih.gov/pubmed/31481814
http://dx.doi.org/10.4314/gmj.v53i2.13
_version_ 1783444428257492992
author Opare, Joseph KL
Akweongo, Patricia
Afari, Edwin A
Odoom, John k
author_facet Opare, Joseph KL
Akweongo, Patricia
Afari, Edwin A
Odoom, John k
author_sort Opare, Joseph KL
collection PubMed
description INTRODUCTION: Ghana was declared polio-free in 2015 after the last polio case in 2008. We determined the poliovirus neutralizing antibody levels among individuals to identify possible immunity gaps. METHODS: A cross-sectional, hospital-based study was undertaken in Northern, Ashanti and Greater Accra regions of Ghana. Individuals referred for haematology at the teaching hospitals' laboratories were invited to participate in our study. Neutralizing-antibody titers to poliovirus serotypes 1,2 & 3 were assayed by WHO-standards. Antibody titers of ≥8 were considered protective. Bivariate and multivariate analyses were conducted on subject characteristics to assess potential factors for failure to seroconvert. P-values < 0.05 were considered statistically significant. RESULTS: Poliovirus (PV) neutralizing-antibody serotypes 1, 2 and 3 were detected in 86.0% (264/307), 84% (258/307) and 75% (230/307) of samples respectively. 60.1% (185/307) were seropositive for the three poliovirus serotypes. Neutralizing poliovirus antibodies for PV1 and PV2 were higher than for PV3. Seroprevalence of poliovirus-neutralizing antibodies among males (PV1=51.9%, PV2= 51.6% and PV3= 52.6%) were higher than in females. Seroprevalence rates of poliovirus-neutralizing antibodies (PV1, PV2, and PV3) were highest in the Northern region (90%, 81%, and 77%). Poliovirus neutralizing-antibodies (PV1and PV2) decreased with age [p< 0.001]. Low seroprevalence of poliovirus-neutralizing antibodies was significantly associated with low school attendance of mothers (p<0.001). CONCLUSION: Our study population has some protection from polio. However, immunity appears to be lower with a higher age or low Mother's education. This may suggest the need for young-adult booster-dose to minimize the risk of wild poliovirus infection. FUNDING: WHO Country Office Ghana.
format Online
Article
Text
id pubmed-6697761
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Ghana Medical Association
record_format MEDLINE/PubMed
spelling pubmed-66977612019-09-03 Poliovirus neutralizing antibody levels among individuals in three regions of Ghana Opare, Joseph KL Akweongo, Patricia Afari, Edwin A Odoom, John k Ghana Med J Original Article INTRODUCTION: Ghana was declared polio-free in 2015 after the last polio case in 2008. We determined the poliovirus neutralizing antibody levels among individuals to identify possible immunity gaps. METHODS: A cross-sectional, hospital-based study was undertaken in Northern, Ashanti and Greater Accra regions of Ghana. Individuals referred for haematology at the teaching hospitals' laboratories were invited to participate in our study. Neutralizing-antibody titers to poliovirus serotypes 1,2 & 3 were assayed by WHO-standards. Antibody titers of ≥8 were considered protective. Bivariate and multivariate analyses were conducted on subject characteristics to assess potential factors for failure to seroconvert. P-values < 0.05 were considered statistically significant. RESULTS: Poliovirus (PV) neutralizing-antibody serotypes 1, 2 and 3 were detected in 86.0% (264/307), 84% (258/307) and 75% (230/307) of samples respectively. 60.1% (185/307) were seropositive for the three poliovirus serotypes. Neutralizing poliovirus antibodies for PV1 and PV2 were higher than for PV3. Seroprevalence of poliovirus-neutralizing antibodies among males (PV1=51.9%, PV2= 51.6% and PV3= 52.6%) were higher than in females. Seroprevalence rates of poliovirus-neutralizing antibodies (PV1, PV2, and PV3) were highest in the Northern region (90%, 81%, and 77%). Poliovirus neutralizing-antibodies (PV1and PV2) decreased with age [p< 0.001]. Low seroprevalence of poliovirus-neutralizing antibodies was significantly associated with low school attendance of mothers (p<0.001). CONCLUSION: Our study population has some protection from polio. However, immunity appears to be lower with a higher age or low Mother's education. This may suggest the need for young-adult booster-dose to minimize the risk of wild poliovirus infection. FUNDING: WHO Country Office Ghana. Ghana Medical Association 2019-06 /pmc/articles/PMC6697761/ /pubmed/31481814 http://dx.doi.org/10.4314/gmj.v53i2.13 Text en Copyright © The Author(s) This is an Open Access article under the CC BY license.
spellingShingle Original Article
Opare, Joseph KL
Akweongo, Patricia
Afari, Edwin A
Odoom, John k
Poliovirus neutralizing antibody levels among individuals in three regions of Ghana
title Poliovirus neutralizing antibody levels among individuals in three regions of Ghana
title_full Poliovirus neutralizing antibody levels among individuals in three regions of Ghana
title_fullStr Poliovirus neutralizing antibody levels among individuals in three regions of Ghana
title_full_unstemmed Poliovirus neutralizing antibody levels among individuals in three regions of Ghana
title_short Poliovirus neutralizing antibody levels among individuals in three regions of Ghana
title_sort poliovirus neutralizing antibody levels among individuals in three regions of ghana
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697761/
https://www.ncbi.nlm.nih.gov/pubmed/31481814
http://dx.doi.org/10.4314/gmj.v53i2.13
work_keys_str_mv AT oparejosephkl poliovirusneutralizingantibodylevelsamongindividualsinthreeregionsofghana
AT akweongopatricia poliovirusneutralizingantibodylevelsamongindividualsinthreeregionsofghana
AT afariedwina poliovirusneutralizingantibodylevelsamongindividualsinthreeregionsofghana
AT odoomjohnk poliovirusneutralizingantibodylevelsamongindividualsinthreeregionsofghana